|
Anavex strengthens management team with addition of VP, Clinical Development & Medical Affairs Sources News Release
http://www.sources.com/Releases/NR1166.htm
Publisher: Dr. Cameron Durrant, MD, MBA, Alzheimer's Disease and Pharmaceuticals/Biot Date Written: 16/02/2011 Year Published: 2011 Resource Type: Article
Anavex Life Sciences Corp. ("ANAVEX") (OTCBB: AVXL) announced the addition of Dr. Angelos Stergiou to the executive management team in the role of Vice President, Clinical Development & Medical Affairs. Dr. Stergiou has extensive medical and clinical
Abstract: Hoboken, NJ February 4, 2011 Anavex Life Sciences Corp. (Anavex, AVXL.OB) today announced the addition of Dr. Angelos Stergiou to the executive management team in the role of Vice President, Clinical Development & Medical Affairs. Dr. Stergiou has extensive medical and clinical development expertise and has been involved in progressing Alzheimers and numerous other clinical trials in prior roles.
"Dr. Stergiou brings more than 10 years of clinical trial management and medical expertis... To read the full release go to http://www.sources.com/Releases/NR1166.htm
Topics
|
AlterLinks
c/o Sources
© 2025.
|
|
|
|